Monday, 1 September 2014
Latest report on DNA sequencing is an excellent piece of material for the market participants to understand the market dynamics. The report titled “Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020,” offers an incisive and wider knowledge about the market.
Next-generation Sequencing technologies are becoming a lethal growth weapon for the overall market.
The technology helps to decode numerous deadly diseases including cancer. Further, it increases the throughput and reduces the sequencing cost. Enabling re-sequencing of human genomes, it helps in identifying the regulatory elements in the pathological process and genes. It is increasingly becoming popular in DNA diagnostics.
Analyst said that the technology is best and economical to find the genetic cause of a disease.
“RNA sequence might replace microarray analysis in gene expression studies in the foreseeable future. Next generation sequencing is a quick and affordable way to determine the genetic causes of diseases. The targeted sequence enables the identification of disease-causing agents for the diagnosis of pathological conditions,” AMR analyst.
Analyst further added “Next generation technology is bridging the gap between traditional and personalized medication. Companies offering next generation sequencing are now focusing on cancer management, rare disease treatment and development of genetic therapies. “
It is a technology that would take DNA sequencing to next level.
Labels: Diagnostic and Biotech
Wednesday, 20 August 2014
The report on hadoop as a service is an excellent piece of work for hadoop market participants to get a wider understanding on it. The report is titled “Global Hadoop-as-a-Service (HaaS) Market (Deployment Types, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020.”
One segment that is forecast to be a winner is the Pure Play/Managed HaaS.
Managed HaaS manages the service solutions swiftly to implement the hadoop needs. One reason for its soaring popularity is that it can be used by any type of organization; especially those organization who don’t have technical domain and has continuous flow of data. Also, companies such as IBM provide complete hadoop services to rip off the burden and assist its clients to concentrate on their core work.
“There might be differences in the way services are provided to the customers. Some companies may require interference from the customers at times to scale and change the number of nodes operating based on workloads. On the other hand, Artiscale is a company that provides a complete solution for customers’ hadoop needs. It eliminates any need for interference even for managing the hadoop functioning. It offers specific tools to customers such as Hive, Pig and R.,” AMR analyst.
Analyst further added, “These tools are designed with the aim of making hadoop management an easy task for even non-techie people. These tools run on specific languages that are much easier than java code input method and therefore make the job submission task easier.”
Hence, the report estimated pure play Haas or managed Haas to be a prominent sector in the overall haas market. North America had the largest share in the year 2013 and would grow significantly by 2020.
Tuesday, 19 August 2014
The global transparent conductive films report is a resourceful material for the market participants in keeping them abreast with the market trends and revenue generation capability. The report has given out a positive wave in the market through is its prediction of a $5.86 billion TCF market by the end of 2020.
The report titled “Global Transparent Conductive Films Market (Technology, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020,” offers clear understanding of the market with insightful data.
So if you wish to know how beneficial TCF is for your business, then get your report now.
Metal mesh is capable of creating rattles in the market. It is deemed to be the most promising segment within the market due to low cost & sheet resistance. Hence, no doubt the number of manufacturers is steadily rising. As per the report, O-film Tech Co Ltd is aspiring to manufacture 1.5 million panels every month.
“In November 2013, O-film Tech Co Ltd., which is the largest touch panel manufacturer in China, officially announced that they would start large-scale production of metal mesh touch panels (TCFs). In the current business scenario, there are a few manufacturers in this segment. As this is an evolving technology, companies need to understand the efficiency of other technologies entering the market. It is likely that a number of companies will start using this technology in the future, “states analyst Ranjan Singh.
“Metal mesh is a comparatively new entrant to the TCF market and possesses various attractive features that make it suitable for TCFs. Metal mesh provides extremely low sheet resistance and is cost effective. However, it cannot be easily customized. These films provide a highly hazy display. This would decrease the clarity of the display in outdoor lighting. Metal mesh TCF can be manufactured through various processes and the number of manufacturers are growing at a rapid rate,” Singh added.
A biosimilar medication called CT-P13 was accepted by the European Medicines Agency to enhance symptoms of ankylosing spondylitis (AS) — including ailment movement, incapacity, and mobility with a drug named infliximab, otherwise called Remicade.
As per a study introduced at the European League Against Rheumatism Annual Congress, CT-P13 is the world's first biosimilar monoclonal immune response to get support and gives a less expensive, more financially savvy alternative for patients with AS. Biosimilars are generic versions of biologic medication.
By demonstrating comparable efficacy and safety, the results of our clinical trials should give physicians confidence in using CT-P13 as an alternative treatment option in AS patients,” Park said. “This is good news for patients who may previously have had limited access to costly antibody biopharmaceuticals.”
“Regulated introduction of biosimilars into the market has been forecasted to increase access to much needed biologic medicines and reduce costs,” the report stated. "The biologic medicines market is expected to grow to $190-200 billion by 2015, with biosimilars a small but growing proportion at $2-2.5 billion.”
One big challenge in front of the approved Biosimilars is not only its similar properties to those traditional medicines that it acts as an alternative, but also being highly effective and safe to be used.
There is a latest report on global biosimilar market, which forecasts the market to reach $35 billion by 2020. Biosimilars are definitely better alternatives to biologics.
Saturday, 9 August 2014
The global 3D printing report is a global gateway to formidable investment in the market. Investors can get actionable insights form the reports for different regions such as North America, Asia-Pacific and Latin America.
The report titled ” Global 3D Printing Market (Technology, Material, Services, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020,” has recognized Stereolithography technology to be the hotspot for growth.
AMR analysts analyzed the above technology to be a hotbed for investors. The technology is mainly used for models, patterns, manufacturing prototypes and production parts. The technology builds the 3D object in layers, starting from the bottom, inside a container filled with liquid polymer. The container is then exposed to a laser beam to harden the liquid.
“In 1986, a patent was issued for this printing technique and the first production system for stereolithography was commercialized in 1988 by 3D systems,” as per the AMR analyst.
Stereolithography developed prototypes are robust and best as master patterns for injection molding, metal casting processes, and blow molding. The main reason for the growth of the technology is that it is time-saving.
“Prototypes produced using stereolithography require less time as compared to other conventional methods. Models developed using stereolithography aid clients in visualizing the product in the form of miniatures even before the production goes live. Stereolithography facilitates conversion of CAD drawings into factual objects or prototypes, which assists in the manufacturing process,” added analysts.
“Microstereolithography is an advanced and high precision SLA technology, which can be employed to develop microlattices, which consist of nanoscale features that comprise of great strength and stiffness along with ultralow density. The microlattice material developed using 3D printing is immensely light and is also referred to as frozen smoke.These lightweight materials can endure a burden of at least 160,000 times their own weight,” said Lita Person, AMR analyst.
Hence, all the superior qualities stated by analysts are the main reason for its growing popularity and its applications in numerous processes such as space vehicles, automobiles, aircrafts, and others.
The global NASH market report by AMR is a clear insight into the billion dollar market. The report titled “Global Nonalcoholic Steatohepatitis (NASH) Market (Pipeline analysis, drug class, clinical trials and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020,” is an excellent piece of report for knowing the market’s trends and revenue generation capabilities.
GFT505, is one of the most potential therapeutic available in the market. GENFIT Biopharmaceutical Company is concentrating on improvement of novel therapeutics utilized to prevent chronic disorders. The organization has created a test model (Gft505) for NASH metabolic issue treatment. This model would help in accepting and exhibiting the correctness and viability of the therapeutic drugs in invivo conditions. The model helps in recognizing the productivity of Gft505 for different metabolic issues, for example, weight, diabetes, dyslipidemia and insulin safety. These maladies are the main cause of hepatic fibrosis and non-alcoholic Steatohepatitis. GENFIT's Gft505 has a capability to reduce the fat substance of liver and has demonstrated positive impacts amid clinical trials. This movement of clinical trial helps expands the likelihood of commercialization for Gft505 in few months. As there is no medicine accessible for the treatment of NASH, Gft505 has better prospects in this business sector.
“GFT505 from Genfit provides treatment solutions for metabolic disorders such as fatty liver diseases or nonalcoholic Steatohepatitis which are the types of metabolic disorders and type II diabetes. GFT505 and GFT1007 comprised of active circulating metabolites that help in reducing the level of plasma triglycerides and cholesterol which is the leading cause of fatty liver diseases. GFT505 also prevents the progression of atherosclerotic plaques during clinical trials in mice. Commercialization for the GFT505 is currently withheld due to safety and efficacy concerns,” states an AMR analyst.
Analyst further added, “According to the leading hepatologists, NASH is a ticking time bomb of fatty liver diseases that requires regulatory support from the respective authorities such as FDA and EMA so as to provide efficient treatment solutions to the healthcare industry.”
The graphene report is an exceptional platform for those investors who wish to invest in the market. The report titled “Global Graphene Market (Product Type, Application, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020,” offers incisive insights into the market revenues and numerous opportunities.
The segment of electronics is poised to have a bombarded growth during the estimated period.
“Graphene, the thinnest and strongest two dimensional compound in the universe is nothing but an allotrope of carbon. This is a thin layer of pure carbon where the single packed layers of carbon atoms are bonded together in a hexagonal honeycomb lattice structure. Due to its unique structure, the compound is is endowed with exceptional physical and chemical characteristics, such as electronics properties, mechanical strength, optical properties etc,” stated Sarah Clark.
North America would generate maximum revenue in the overall graphene market during the analyzed period. This can be credited to the increased sales of advanced technological gadgets such as touch screen devices or energy saving devices.
“The ballistic transport of its electron results in the high conductivity of the material as a result of which the material possesses a wide range of applications in electronics industry, such as transparent conductors, optical switches, conductive inks, high frequency transistors and integrated circuits, memory devices etc. Graphene could bring about a transformation in the smart phone industry due to its ability to produce flexible, conductive and unbreakable touch screens. In mobile screen, graphene conductive ink can be printed over the thin plastic surface instead of glass. As a result, the mobile phone could be light, flexible and as thin as a piece of paper. Moreover, the strongest material would also make the cell phone unbreakable,” added the analyst.
Characteristics that make graphene apt in electronic segment are its higher electronic quality, higher optical transparency and larger surface area. Furthermore, the transfer of electron is 200 times faster than silicon conductors due to its ability of being zero gap semiconductors.
Labels: Materials & Chemicals